Laurence Rulleau Ph.d.
Chairman of the Board of Directors
immunology
NeoMed
Brunei Darussalam
Biography
Dr. Rulleau, Ph.D is a partner at CTI Life Sciences Fund, a life sciences venture capital fund. Dr. Rulleau has served as a life sciences analyst covering the Canadian life sciences sector for more than 10 years. As an analyst, she covered over 100 life sciences companies including scientific due diligence, market and competitive analysis. Dr. Rulleau was ranked the #1 Canadian life sciences analyst by the Starmine survey and #1 independent analyst by Brendon Wood survey. Dr. Rulleau has been involved in numerous mergers and acquisitions as well as IPOs.
Research Interest
Dr. Rulleau, Ph.D is a partner at CTI Life Sciences Fund, a life sciences venture capital fund. Dr. Rulleau has served as a life sciences analyst covering the Canadian life sciences sector for more than 10 years. As an analyst, she covered over 100 life sciences companies including scientific due diligence, market and competitive analysis. Dr. Rulleau was ranked the #1 Canadian life sciences analyst by the Starmine survey and #1 independent analyst by Brendon Wood survey. Dr. Rulleau has been involved in numerous mergers and acquisitions as well as IPOs.
